Page last updated: 2024-12-04

indole-3-acetaldehyde

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

indoleacetaldehyde : An aldehyde that is acetaldehyde substituted by an indolyl group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

indol-3-ylacetaldehyde : An indoleacetaldehyde that is acetaldehyde in which one of the methyl hydrogens are replaced by a indol-3-yl group. It is an intermediate metabolite in the metabolism of tryptophan. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID800
CHEBI ID18086
SCHEMBL ID107104
MeSH IDM0041923

Synonyms (27)

Synonym
indol-3-ylacetaldehyde
1h-indol-3-ylacetaldehyde
CHEBI:18086
1h-indole-3-acetaldehyde
(indol-3-yl)acetaldehyde
indole-3-acetaldehyde
C00637
indole acetaldehyde
2-(indol-3-yl)acetaldehyde
2591-98-2
indoleacetaldehyde
3AA2B26B-6E90-473F-AE5E-CBF2BB1ACB49
2-(1h-indol-3-yl)acetaldehyde
AKOS006237176
unii-a346h8e8wu
a346h8e8wu ,
ccris 5808
FT-0646077
AB02302
SCHEMBL107104
indol-3-acetaldehyde
1h-indol-3-ylacetaldehyde #
DTXSID90180582
tryptaldehyde
2-(3-indolyl)acetaldehyde
Q27102813
EN300-1601797
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (4)

RoleDescription
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
Saccharomyces cerevisiae metaboliteAny fungal metabolite produced during a metabolic reaction in Baker's yeast (Saccharomyces cerevisiae).
bacterial metaboliteAny prokaryotic metabolite produced during a metabolic reaction in bacteria.
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
indoleacetaldehydeAn aldehyde that is acetaldehyde substituted by an indolyl group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (16)

PathwayProteinsCompounds
Tryptophan Metabolism1855
L-tryptophan degradation VI (via tryptamine)313
Tryptophan degradation ( Tryptophan degradation )6454
Renz2020 - GEM of Human alveolar macrophage with SARS-CoV-20490
tryptophan degradation via tryptamine416
superpathway of tryptophan utilization4292
indole-3-acetate biosynthesis VI (bacteria)219
L-tryptophan degradation V (side chain pathway)020
L-tryptophan degradation X (mammalian, via tryptamine)519
L-tryptophan degradation VIII (to tryptophol)1213
L-tryptophan degradation VI (via tryptamine)319
tryptophan degradation VIII (to tryptophol)1213
IAA biosynthesis I025
tryptophan degradation X (mammalian, via tryptamine)015
Tryptophan degradation07
Biochemical pathways: part I0466
Amino acid metabolism094
IAA biosynthesis I021

Research

Studies (28)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (39.29)18.7374
1990's1 (3.57)18.2507
2000's2 (7.14)29.6817
2010's10 (35.71)24.3611
2020's4 (14.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 39.35

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index39.35 (24.57)
Research Supply Index3.37 (2.92)
Research Growth Index5.36 (4.65)
Search Engine Demand Index51.54 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (39.35)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other28 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]